In this section of the Eisai Inc. Newsroom you'll find video clips that are viewable using either Windows Media Player, Real Player or Quicktime. Please click on the thumbnail image or the link to view the clip.

Tackling Lymphatic Filariasis: Eisai Providing Greater Access to Medicines
As a signatory to the London Declaration, Eisai is committed to helping eliminate neglected tropical diseases (NTDs). In January 2012, the company agreed to provide the World Health Organization (WHO) with 2.2 billion diethylcarbamazine (DEC) tablets at price zero (free of charge) for the treatment and control of lymphatic filariasis, which affects 120 million people in 73 countries. Eisai has been providing DEC tablets, which are manufactured at its state-of-the-art Vizag Plant in India, to WHO since October 2013, and has further pledged to distribute DEC tablets to some 250 million people living in at-risk communities worldwide over the next seven years. The video below outlines some of the challenges in realizing greater access to medicines, as well as Eisai's efforts to help eliminate lymphatic filariasis.
Television Ad Campaign for BELVIQ® (lorcaserin HCl) CIV
Eisai has launched its national television advertising campaign for BELVIQ®. The commercial is a follow-up to the national print advertising campaign for BELVIQ that began in October 2013.
Magnolia® Meals at Home® - A meal delivery program + so much more
Magnolia Meals at Home is a meal delivery program that helps provide a nutritious foundation for patients living with breast cancer and their families. The goal of the program is to help ease the stress of daily living so that patients can enjoy shared moments with loved ones. Equally as important, it gives Eisai and its employees a hands-on, interactive opportunity to get involved in the local community. Watch this inspirational video to learn more about the program. (Magnolia® and Magnolia Meals at Home® are trademarks of Eisai Inc.)